Catalyst
Slingshot members are tracking this event:
Akcea Therapeutics Announces Completion of Enrollment in Phase 3 COMPASS Trial of Volanesorsen
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IONS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Completion Of Enrollment, Phase 3 Compass Trial, Volanesorsen, Hypertriglyceridemia, Compass Study, Cardiometabolic Diseases
